Structure-based design of human TLR8-specific agonists with augmented potency and adjuvanticity Structure-based design of human TLR8-specific agonists with augmented potency and adjuvanticity Structure-based design of human TLR8-specific agonists with augmented potency and adjuvanticity Giuseppe Caruso2021-09-05T15:31:33+01:00October 8th, 2015|Vaccine adjuvants and toll-like receptors| Beesu M, Caruso G, Salyer AC, Khetani KK, Sil D, W [...]